Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study. Biomol Biomed [Internet]. 2024 Jun. 25 [cited 2024 Jul. 2];. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/10512